Regulatory & Legal

A new device acts as a security system for your air, monitoring invisible threats like mold. But can consumer tech truly deliver on this bold promise?

Belgian firm Endo Tools Therapeutics wins US approval for its next-gen endomina® EZFuse, a device promising to cut GI procedure times by up to 50%.

Amid a global scramble for critical minerals, one company's advanced airborne tech promises faster, greener, and more secure resource discovery.

Galectin Therapeutics adds legendary neurosurgeon Dr. Henry Brem to its board, a strategic move to leverage his drug development expertise for its lead liver drug.

Exiting stealth, PerturbAI releases an 8-million-cell map of gene function in a living brain, aiming to slash the cost and time of creating new drugs.

As Xsolla SPAC 1's shares and warrants begin separate trading, the firm's expert team starts its search for a billion-dollar target in gaming and fintech.

Jaguar Uranium re-analyzes old drill cores in Colombia, hunting for rare earths in a bid to create a new, non-Chinese critical minerals hub for the West.

UK biotech Alchemab hires Sanofi's Ulrich Wendt as CBO to forge major pharma deals for its novel AI platform that mines the secrets of human resilience.

The battery maker reports record revenue and a vastly improved bottom line for 2025, but misses guidance amid regulatory shifts and customer delays.

A new exoskeleton, validated by scientific studies, shows a dramatic reduction in muscle strain and discomfort for surgeons, dentists, and industrial workers.

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

Getty Images posts its highest revenue in 30 years, but a massive net loss, shrinking customer base, and a UK merger review cloud its financial future.

Aerospace tech firm Merlin lands on NASDAQ, securing capital to scale its AI-powered autonomous flight system for military and future civilian aircraft.

The abrdn Global Infrastructure Income Fund wants to remove its 2035 termination date, offering shareholders lower fees in exchange for a perpetual structure.

Eve's eVTOL prototype is flying and its finances are secure through 2028, positioning the Embraer-backed company as a top contender in the air taxi race.

A landmark partnership gives Manitoba's beef industry a 467-acre living lab to test innovations that boost profitability and environmental resilience.

A new prenatal vitamin tackles the 'choline gap,' a nutrient deficiency affecting 90% of pregnant women that is crucial for fetal brain development.

As essential pediatric care costs skyrocket, families of children with cerebral palsy face a silent crisis of debt, stress, and impossible choices.

The French banking giant realigns its reporting to reflect key strategic shifts, offering investors a more transparent view of its future performance.

A major acquisition positions a global analytics firm to lead Alberta's power market as it undergoes a complex and controversial restructuring.